Recent Advances in Targeted Nanotherapies for Ischemic Stroke

Area of Science:

• Neurology
• Biomedical Engineering
• Nanotechnology

Background:

• Ischemic stroke (IS) is a major cause of death and disability due to cerebral blood vessel occlusion.
• Current IS treatments are limited by drug bioavailability and stability issues.
• Nanomedicine presents novel therapeutic avenues for IS diagnosis and treatment.

Purpose of the Study:

• To review recent advancements in nanomedicine for ischemic stroke (IS) therapy.
• To explore nanotherapeutic strategies for drug delivery, neuroprotection, and targeting in IS.
• To discuss the role and potential neurotoxic effects of inorganic metal nanoparticles in IS treatment.

Main Methods:

• Literature review of recent developments in nanomedicine for IS.
• Analysis of nanotherapeutic approaches including drug delivery, neuroprotection, and targeting.
• Evaluation of inorganic metal nanoparticles in IS therapy.

Main Results:

• Nanotherapeutics show potential for improved drug accumulation, controlled release, and enhanced restorative properties in IS.
• Strategies discussed include assisted drug delivery, neuroprotection via environmental regulation, and biomimetic targeting.
• Inorganic metal nanoparticles are being investigated for their role and potential neurotoxic effects in IS therapy.

Conclusions:

• Nanomedicine offers significant potential for developing novel and effective therapies for ischemic stroke.
• Advanced nanotherapeutics can overcome limitations of conventional IS treatments, improving drug delivery and efficacy.
• This review provides a foundation for utilizing nano-IS therapies in treating embolic diseases.